Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas

Journal of Gastroenterology

Volumn 45, Issue 7, 2010, Pages 763-770

  Satoh, Kennichi ^a   Hamada, Shin ^a   Kanno, Atsushi ^a   Hirota, Morihisa ^a   Umino, Jun ^a   Ito, Hiromichi ^a   Masamune, Atsushi ^a   Egawa, Shinichi ^a   Unno, Michiaki ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intraductal papillary mucinous neoplasm of the pancreas; MSX2

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR MSX2; HOMEODOMAIN PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MICRODISSECTION; PANCREAS CANCER; PANCREAS CELL; PANCREAS RESECTION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; CELL LINE; COLLOID CARCINOMA; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIVARIATE ANALYSIS; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PAPILLARY CARCINOMA; PATHOLOGY; PREDICTIVE VALUE;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MULTIVARIATE ANALYSIS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77955658629     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0200-1     Document Type: Article

References (44)

1. JEV Loftus BA Olivares-Pakzad KP Batts MC Adkins DH Stephens MG Sarr, et al. 1996 Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature Gastroenterology 110 1909 1918 10.1053/gast.1996.v110.pm8964418 8964418 (Pubitemid 26169229)
2. B Terris P Ponsot F Paye P Hammel A Sauvanet G Molas, et al. 2000 Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct Am J Surg Pathol 24 1372 1377 10.1097/00000478- 200010000-00006 1:STN:280:DC%2BD3cvmvVagtw%3D%3D 11023098
3. T Hara T Yamaguchi T Ishihara T Tsuyuguchi F Kondo K Kato, et al. 2002 Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography Gastroenterology 122 34 43 10.1053/gast.2002.30337 11781278
4. M Kobari S Egawa K Shibuya H Shimamura M Sunamura K Takeda, et al. 1999 Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management Arch Surg 134 1131 1136 10.1001/archsurg.134.10.1131 1:STN:280:DyaK1MvltVKqtw%3D%3D 10522860 (Pubitemid 29473205)
5. R Doi K Fujimoto M Wada M Imamura 2002 Surgical management of intraductal papillary mucinous tumor of the pancreas Surgery 132 80 85 10.1067/msy.2002. 125386 12110799 (Pubitemid 34787825)
6. T Matsumoto M Aramaki K Yada S Hirano Y Himeno K Shibata, et al. 2003 Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas J Clin Gastroenterol 36 261 265 10.1097/00004836- 200303000-00014 12590239 (Pubitemid 36232639)
7. Y Kitagawa TA Unger S Taylor RA Kozarek LW Traverso 2003 Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas J Gastrointest Surg 7 12 18 10.1016/S1091-255X(02)00152-X 12559180 discussion 18-19. (Pubitemid 36875796)
8. M Sugiyama Y Izumisato N Abe T Masaki T Mori Y Atomi 2003 Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas Br J Surg 90 1244 1249 10.1002/bjs.4265 1:STN:280:DC%2BD3svltl2htg%3D%3D 14515294 (Pubitemid 37330429)
9. K Satoh T Sawai T Shimosegawa M Koizumi T Yamazaki F Mochizuki, et al. 1993 The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin-hypersecreting neoplasm of the pancreas Int J Pancreatol 14 135 143 1:CAS:528:DyaK2cXitFequ7Y%3D 8283077 (Pubitemid 23326232)
10. K Satoh T Shimosegawa S Moriizumi M Koizumi T Toyota 1996 K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas Pancreas 12 362 368 10.1097/00006676-199605000-00007 1:STN:280:DyaK28zhtVClsw%3D%3D 8740403
11. K Satoh A Kanno S Hamada M Hirota J Umino A Masamune, et al. 2008 Expression of Sonic hedgehog signaling pathway correlates with the tumorigenesis of intraductal papillary mucinous neoplasm of the pancreas Oncol Rep 19 1185 1190 1:CAS:528:DC%2BD1cXmtFKqs7o%3D 18425375
12. K Satoh H Sasano T Shimosegawa M Koizumi T Yamazaki F Mochizuki, et al. 1993 An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas Cancer 72 51 56 10.1002/1097-0142(19930701)72:1<51::AID- CNCR2820720112>3.0.CO;2-O 1:STN:280:DyaK3s3osVKjsw%3D%3D 8099533
13. K Satoh K Kaneko M Hirota A Masamune A Satoh T Shimosegawa 2001 Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors Cancer 92 271 278 10.1002/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0 1:STN:280:DC%2BD3Mvhs1yrtw%3D%3D 11466679 (Pubitemid 32664432)
14. S Fukushige T Furukawa K Satoh M Sunamura M Kobari M Koizumi, et al. 1998 Loss of chromosome 18q is an early event in pancreatic ductal tumorigenesis Cancer Res 58 4222 4226 1:CAS:528:DyaK1cXmsVyqs7w%3D 9766641
15. M Sugiyama Y Atomi M Saito 1998 Intraductal papillary tumors of the pancreas: evaluation with endoscopic ultrasonography Gastrointest Endosc 48 164 171 10.1016/S0016-5107(98)70158-0 1:STN:280:DyaK1czotFyrsA%3D%3D 9717782 (Pubitemid 28387462)
16. H Yasuda T Takada H Amano M Yoshida 1998 Surgery for mucin-producing pancreatic tumor Hepatogastroenterology 45 2009 2015 1:STN:280: DyaK1M7jsFehtA%3D%3D 9951855
17. SY Lee KT Lee JK Lee YH Jeon D Choi JH Lim, et al. 2005 Long-term follow up results of intraductal papillary mucinous tumors of pancreas J Gastroenterol Hepatol 20 1379 1384 10.1111/j.1440-1746.2005.04014.x 16105124 (Pubitemid 43960835)
18. LW Traverso 2002 Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: the aggressive approach J Gastrointest Surg 6 662 663 10.1016/S1091-255X(02)00059-8 12399053 (Pubitemid 40433482)
19. P Bernard JY Scoazec M Joubert X Kahn J Le Borgne F Berger, et al. 2002 Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases Arch Surg 137 1274 1278 10.1001/archsurg.137.11.1274 12413317
20. H Irie K Yoshimitsu H Aibe T Tajima A Nishie T Nakayama, et al. 2004 Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography J Comput Assist Tomogr 28 117 122 10.1097/00004728-200401000-00020 14716244 (Pubitemid 38057866)
21. G Kobayashi N Fujita Y Noda K Ito J Horaguchi O Takasawa, et al. 2005 Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS J Gastroenterol 40 744 751 10.1007/s00535-005-1619-7 16082592 (Pubitemid 41349087)
22. M Tanaka 2007 International consensus guidelines for the management of IPMN and MCN of the pancreas Nippon Shokakibyo Gakkai Zasshi 104 1338 1343 17827904
23. M Pelaez-Luna ST Chari TC Smyrk N Takahashi JE Clain MJ Levy, et al. 2007 Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients Am J Gastroenterol 102 1759 1764 10.1111/j.1572-0241.2007.01224.x 17686073 (Pubitemid 47206677)
24. Y Takahashi N Le Douarin 1990 cDNA cloning of a quail homeobox gene and its expression in neural crest-derived mesenchyme and lateral plate mesoderm Proc Natl Acad Sci USA 87 7482 7486 10.1073/pnas.87.19.7482 1:CAS:528: DyaK3MXitVSlur0%3D 1977161 (Pubitemid 20341740)
25. DR Davidson A Crawley RE Hill C Tickle 1991 Position-dependent expression of two related homeobox genes in developing vertebrate limbs Nature 352 429 431 10.1038/352429a0 1:STN:280:DyaK3MzhvFajug%3D%3D 1677742
26. AK Jowett S Vainio MW Ferguson PT Sharpe I Thesleff 1993 Epithelial-mesenchymal interactions are required for msx 1 and msx 2 gene expression in the developing murine molar tooth Development 117 461 470 1:STN:280:DyaK3szitFGqsQ%3D%3D 8101167
27. DJ Phippard SJ Weber-Hall PT Sharpe MS Naylor H Jayatalake R Maas, et al. 1996 Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development Development 122 2729 2737 1:CAS:528:DyaK28XlvFCktrY%3D 8787747
28. M Suzuki M Tanaka T Iwase Y Naito H Sugimura I Kino 1993 Over-expression of HOX-8, the human homologue of the mouse Hox-8 homeobox gene, in human tumors Biochem Biophys Res Commun 194 187 193 10.1006/bbrc.1993.1802 1:CAS:528:DyaK3sXkvFals7w%3D 7687426 (Pubitemid 23237918)
29. S Hamada K Satoh M Hirota K Kimura A Kanno A Masamune, et al. 2007 Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line J Cell Physiol 213 768 774 10.1002/jcp.21148 1:CAS:528:DC%2BD2sXht12jur3I 17516553 (Pubitemid 350058270)
30. K Satoh S Hamada K Kimura A Kanno M Hirota J Umino, et al. 2008 Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells Am J Pathol 172 926 939 10.2353/ajpath.2008.070346 1:CAS:528:DC%2BD1MXislOhsLc%3D 18349132 (Pubitemid 351519990)
31. Longnecker DS, Adler G, Hruban RH, Kloppel G. Intraductal papillary mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, editors. Pathology and genetics. Tumours of the digestive system. WHO classification of tumours. Lyon: IARC Press; 2000. p. 237-40.
32. T Furukawa WP Duguid L Rosenberg J Viallet DA Galloway MS Tsao 1996 Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16 Am J Pathol 148 1763 1770 1:STN:280:DyaK283jsValsw%3D%3D 8669463
33. K Specht T Richter U Muller A Walch M Werner H Hofler 2001 Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue Am J Pathol 158 419 429 1:CAS:528: DC%2BD3MXhsFWmtrk%3D 11159180
34. J Kim HA Reber OJ Hines KK Kazanjian A Tran X Ye, et al. 2006 The clinical significance of MAGEA3 expression in pancreatic cancer Int J Cancer 118 2269 2275 10.1002/ijc.21656 1:CAS:528:DC%2BD28XjsVCgt7g%3D 16331618
35. K Ohuchida K Mizumoto H Fujita H Yamaguchi H Konomi E Nagai, et al. 2006 Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice J Pathol 210 42 48 10.1002/path.2019 1:CAS:528:DC%2BD28XpvFaru70%3D 16794990 (Pubitemid 44288179)
36. C Takahashi N Akiyama T Matsuzaki S Takai H Kitayama M Noda 1996 Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene Oncogene 12 2137 2146 1:CAS:528:DyaK28Xjtl2rtbs%3D 8668339
37. M Dodig T Tadic MS Kronenberg S Dacic YH Liu R Maxson, et al. 1999 Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation Dev Biol 209 298 307 10.1006/dbio.1999.9258 1:CAS:528:DyaK1MXislOhsL4%3D 10328922 (Pubitemid 29230881)
38. YH Liu Z Tang RK Kundu L Wu W Luo D Zhu, et al. 1999 Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans Dev Biol 205 260 274 10.1006/dbio.1998.9114 1:CAS:528:DyaK1MXhtVeisbo%3D 9917362 (Pubitemid 29066384)
39. K Satoh E Ginsburg BK Vonderhaar 2004 Msx-1 and Msx-2 in mammary gland development J Mammary Gland Biol Neoplasia 9 195 205 10.1023/B:JOMG.0000037162. 84758.b5 15300013 (Pubitemid 39177503)
40. K Satoh RC Hovey T Malewski A Warri AS Goldhar E Ginsburg, et al. 2007 Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2 Oncogene 26 7526 7534 10.1038/sj.onc.1210555 1:CAS:528:DC%2BD2sXhtlKmurvI 17546050 (Pubitemid 350207704)
41. JR Brody A Witkiewicz TK Williams SS Kadkol J Cozzitorto B Durkan, et al. 2007 Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia Mod Pathol 20 1238 1244 10.1038/modpathol.3800974 1:CAS:528: DC%2BD2sXhtlSmtbnJ 17906614 (Pubitemid 350126858)
42. J Bai JR Brody SS Kadkol GR Pasternack 2001 Tumor suppression and potentiation by manipulation of pp32 expression Oncogene 20 2153 2160 10.1038/sj.onc.1204294 1:CAS:528:DC%2BD3MXjsVChtLw%3D 11360199 (Pubitemid 32424009)
43. AV Biankin SA Biankin JG Kench AL Morey CS Lee DR Head, et al. 2002 Aberrant p16 (INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma Gut 50 861 868 10.1136/gut.50.6.861 1:CAS:528:DC%2BD38XkvVGktLw%3D 12010891 (Pubitemid 34539051)
44. Y Hirooka H Goto A Itoh S Hashimoto K Niwa H Ishikawa 2003 Case of intraductal papillary mucinous tumor in which endosonography-guided fine-needle aspiration biopsy caused dissemination J Gastroenterol Hepatol 18 1323 1324 10.1046/j.1440-1746.2003.03040.x 14535994 (Pubitemid 37464012)